# Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

> **NCT00696007** · PHASE2 · WITHDRAWN · sponsor: **Lahey Clinic**

## Conditions studied

- Transitional Cell Carcinoma

## Interventions

- **DRUG:** Gemcitabine and cisplatin
- **OTHER:** Retrospective comparison

## Key facts

- **NCT ID:** NCT00696007
- **Lead sponsor:** Lahey Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was unable to recruit subjects meeting the study requirements.
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696007, "Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00696007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*